APA (7th ed.) Citation

JPN, P., J, Y., MJ, H., L, Z., RI, R., NF, W., . . . JA, T. (2026). Discovery of EGT710, an Oral Nonpeptidomimetic Reversible Covalent SARS-CoV-2 Main Protease Inhibitor. Journal of medicinal chemistry, 69(4), 3868. https://doi.org/10.1021/acs.jmedchem.5c02360

Chicago Style (17th ed.) Citation

JPN, Papillon, et al. "Discovery of EGT710, an Oral Nonpeptidomimetic Reversible Covalent SARS-CoV-2 Main Protease Inhibitor." Journal of Medicinal Chemistry 69, no. 4 (2026): 3868. https://doi.org/10.1021/acs.jmedchem.5c02360.

MLA (9th ed.) Citation

JPN, Papillon, et al. "Discovery of EGT710, an Oral Nonpeptidomimetic Reversible Covalent SARS-CoV-2 Main Protease Inhibitor." Journal of Medicinal Chemistry, vol. 69, no. 4, 2026, p. 3868, https://doi.org/10.1021/acs.jmedchem.5c02360.